Eli Lilly CFO Lucas Montarce Settles RSUs with Routine Tax Withholding
ELI LILLY & Co
Subscribe to track LLY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š Form 4 Filing: ELI LILLY & Co ($LLY) Insider: Lucas Montarce (EVP & CFO) Transaction Date: November 1, 2026
Details: ā¢ Acquired: 1,610 shares via RSU vesting ($0.00) ā¢ Disposed (Tax Withholding): 677.593 shares @ $1,417.54 ($960,515.97) ā¢ Shares Retained Post-Transaction: 17,190.88 directly owned
Significance: Low (Routine RSU vesting & mandatory tax withholding)
Comprehensive Analysis
Executive Summary
On November 3, 2026, Eli Lilly & Co ($LLY) filed a Form 4 on behalf of Executive Vice President and Chief Financial Officer Lucas Montarce. The filing details the vesting of 1,610 restricted stock units (RSUs) on November 1, 2026, and the subsequent automatic withholding of 677.593 common shares to satisfy tax obligations at an evaluated price of $1,417.54 per share.
Transaction Breakdown
- Derivative Conversion (Code M):
- Security: Restricted Stock Units
- Shares Converted: 1,610 shares of Common Stock at $0 exercise price.
- Tax Withholding Disposition (Code F):
- Security: Common Stock
- Shares Withheld: 677.593 shares
- Price per Share: $1,417.54
- Total Withheld Value: ~$960,515.97
- Post-Transaction Direct Holdings: 17,190.88 shares
Market & Trading Significance
This transaction carries Low significance. It reflects ordinary equity compensation vesting and customary tax-withholding mechanisms rather than discretionary open-market buying or selling by the CFO.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.